539 related articles for article (PubMed ID: 7661937)
41. Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2).
Woods KL; Fletcher S; Roffe C; Haider Y
Lancet; 1992 Jun; 339(8809):1553-8. PubMed ID: 1351547
[TBL] [Abstract][Full Text] [Related]
42. The plasma concentrations of isosorbide 5-mononitrate (5-ISMN) administered in an extended-release form to patients with acute myocardial infarction.
McClennen W; Hornestam B; Jonsson UE; Held P
Br J Clin Pharmacol; 1995 Jun; 39(6):704-8. PubMed ID: 7654494
[TBL] [Abstract][Full Text] [Related]
43. Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial.
Kenchaiah S; Davis BR; Braunwald E; Rouleau JL; Dagenais GR; Sussex B; Steingart RM; Brown EJ; Lamas GA; Gordon D; Bernstein V; Pfeffer MA;
Am Heart J; 2004 Aug; 148(2):356-64. PubMed ID: 15309009
[TBL] [Abstract][Full Text] [Related]
44. Effects of captopril on ventricular arrhythmias in the early and late phase of suspected acute myocardial infarction. Randomized, placebo-controlled substudy of ISIS-4.
Budaj A; Cybulski J; Cedro K; Karczmarewicz S; Maciejewicz J; Wiśniewski M; Ceremuzyński L
Eur Heart J; 1996 Oct; 17(10):1506-10. PubMed ID: 8909907
[TBL] [Abstract][Full Text] [Related]
45. Combined captopril and isosorbide dinitrate during healing after myocardial infarction. Effect on ventricular remodeling, function, mass and collagen.
Jugdutt BI; Khan MI; Jugdutt SJ; Blinston GE
J Am Coll Cardiol; 1995 Apr; 25(5):1089-96. PubMed ID: 7897121
[TBL] [Abstract][Full Text] [Related]
46. Patient compliance with once-daily and twice-daily oral formulations of 5-isosorbide mononitrate: a comparative study.
Brun J
J Int Med Res; 1994; 22(5):266-72. PubMed ID: 7867871
[TBL] [Abstract][Full Text] [Related]
47. Randomised trial of late thrombolysis in patients with suspected acute myocardial infarction. EMERAS (Estudio Multicéntrico Estreptoquinasa Repúblicas de América del Sur) Collaborative Group.
Lancet; 1993 Sep; 342(8874):767-72. PubMed ID: 8103875
[TBL] [Abstract][Full Text] [Related]
48. Which patient benefits from early angiotensin-converting enzyme inhibition after myocardial infarction? Results of one-year serial echocardiographic follow-up from the Captopril and Thrombolysis Study (CATS).
van Gilst WH; Kingma JH; Peels KH; Dambrink JH; St John Sutton M
J Am Coll Cardiol; 1996 Jul; 28(1):114-21. PubMed ID: 8752803
[TBL] [Abstract][Full Text] [Related]
49. [Magnesium in myocardial infarct].
Lüderitz B
Dtsch Med Wochenschr; 1994 Aug; 119(31-32):1102-3. PubMed ID: 8055754
[No Abstract] [Full Text] [Related]
50. Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction.
Redfield MM; Anstrom KJ; Levine JA; Koepp GA; Borlaug BA; Chen HH; LeWinter MM; Joseph SM; Shah SJ; Semigran MJ; Felker GM; Cole RT; Reeves GR; Tedford RJ; Tang WH; McNulty SE; Velazquez EJ; Shah MR; Braunwald E;
N Engl J Med; 2015 Dec; 373(24):2314-24. PubMed ID: 26549714
[TBL] [Abstract][Full Text] [Related]
51. Randomized, double-blind, placebo-controlled long-term study of isosorbide-5-mononitrate therapy in patients with left ventricular dysfunction after acute myocardial infarction.
Tingberg E; Roijer A; Thilen U; Eskilsson J; Ohlin H
Am Heart J; 2003 Jan; 145(1):E1. PubMed ID: 12514673
[TBL] [Abstract][Full Text] [Related]
52. The effects of oral isosorbide 5-mononitrate on mortality following acute myocardial infarction: a multicentre study.
Fitzgerald LJ; Bennett ED
Eur Heart J; 1990 Feb; 11(2):120-6. PubMed ID: 2178930
[TBL] [Abstract][Full Text] [Related]
53. [The use of oral and intravenous isosorbide mononitrate (5-MNi) in the acute phase of myocardial infarction].
Rezende M
Rev Port Cardiol; 1993 Mar; 12 Suppl 1():I35-8. PubMed ID: 8499118
[TBL] [Abstract][Full Text] [Related]
54. Six-month effects of early treatment with lisinopril and transdermal glyceryl trinitrate singly and together withdrawn six weeks after acute myocardial infarction: the GISSI-3 trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico.
J Am Coll Cardiol; 1996 Feb; 27(2):337-44. PubMed ID: 8557903
[TBL] [Abstract][Full Text] [Related]
55. [Selection of therapy with nitrates in patients with stable effort angina: results of comparative study of common isosorbide dinitrate and long acting preparation of isosorbide-5-mononitrate].
Martsevich SIu; Semenova IuE; Alimova EV; Dmitrieva nA; Kozyreva MP; Koniakhina IP; Lukina IuV; Egorov VA
Kardiologiia; 2005; 45(11):42-5. PubMed ID: 16353064
[TBL] [Abstract][Full Text] [Related]
56. Acute administration of angiotensin converting enzyme inhibitors in thrombolysed myocardial infarction patients is associated with a decreased incidence of heart failure, but an increased re-infarction risk.
Voors AA; de Kam PJ; van den Berg MP; Borghi C; Hochman JS; van Veldhuisen DJ; van Gilst WH
Cardiovasc Drugs Ther; 2005 Mar; 19(2):119-24. PubMed ID: 16025230
[TBL] [Abstract][Full Text] [Related]
57. First dose hypotension after angiotensin converting enzyme inhibitor captopril and angiotensin II blocker losartan in patients with acute myocardial infarction.
Spinar J; Vitovec J; Pluhacek L; Spinarova L; Fischerova B; Toman J
Int J Cardiol; 2000 Sep; 75(2-3):197-204. PubMed ID: 11077134
[TBL] [Abstract][Full Text] [Related]
58. Early intravenous magnesium administration in acute myocardial infarction.
Fernandes JS
Magnes Res; 1994 Dec; 7(3-4):341-3. PubMed ID: 7786697
[No Abstract] [Full Text] [Related]
59. Does the addition of losartan improve the beneficial effects of ACE inhibitors in patients with anterior myocardial infarction? A pilot study.
Di Pasquale P; Bucca V; Scalzo S; Cannizzaro S; Giubilato A; Paterna S
Heart; 1999 Jun; 81(6):606-11. PubMed ID: 10336919
[TBL] [Abstract][Full Text] [Related]
60. Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema.
Cotter G; Metzkor E; Kaluski E; Faigenberg Z; Miller R; Simovitz A; Shaham O; Marghitay D; Koren M; Blatt A; Moshkovitz Y; Zaidenstein R; Golik A
Lancet; 1998 Feb; 351(9100):389-93. PubMed ID: 9482291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
